Delivery Order SPE2D021DA002-SPE2D325F030E

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of 4,565,118,241 units of the TWINRIX vaccine syringe. The contract has an ultimate completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes to the DLA. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,602.92 and is for the delivery of the TWINRIX vaccine syringe to military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,808.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX VACCINE SYRINGE and has an ultimate completion date of August 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of the TWINRIX VACCINE SYRINGE with a ceiling value of $16,366.20 and a period of performance through April 9, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order (SPE2D021DA002|SPE2D325F0923) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,014.60 contract is for the delivery of 4566244616 units of the TWINRIX VACCINE SYRINGE. The contract has an ultimate completion date of October 29, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of the TWINRIX vaccine syringe. The contract has a firm fixed-price pricing type and a completion date of April 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, contract 4600082013 under the...
This is a federal contract award to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $4,007.30 fixed-price delivery order contract was issued by the Defense Logistics Agency (DLA) on March 13, 2024 and has an ultimate completion date of March 14, 2024. The contract is for the delivery of TWINRIX vaccine syringes to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,546.48, is for the delivery of TWINRIX VACCINE SYRINGE, a specialized pharmaceutical product, by March 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F030E
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,636.62, is for the delivery of 4,568,085,988 units of the TWINRIX vaccine syringe. The contract has a period of performance through May 1, 2025. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a range of pharmaceutical products. This contract award demonstrates DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 8/3/25, 1:04 AM